Why Insurance Doesn't Cover Getting Better

Start Here

If you've ever asked why your insurance won't cover a treatment that might actually help you, you're asking the right question.

Usually that question comes after you've already tried the standard path. Multiple appointments. Medications that changed your labs but not how you feel. A sense that something is still unresolved, even if everything looks 'managed.

The frustration behind that question is legitimate. You've paid premiums for years. You have a real condition. You're looking for real answers. And you're being told, in one form or another, that what you need isn't covered.

The answer to that question isn't that the system is broken. The answer is that the system is working exactly as it was designed to work. And the design was never built around the kind of problem you have.

Understanding that distinction doesn't make the situation easier financially. But it does make it clearer. And clarity is more useful than frustration when you're trying to figure out what to do next.

What the Insurance Model Was Built For

The modern insurance model was designed around acute care. A broken bone. An infection requiring antibiotics. An appendix that needs to come out. A cardiac event that needs immediate intervention.

These are problems with clear, defined endpoints. Something happens. A specific intervention addresses it. The problem resolves. The intervention has a code. The code gets billed. The system works.

The model was also built around standardization. For a treatment to be reimbursed, it needs to be repeatable, codable, and applicable to a defined diagnosis. The same diagnosis gets the same treatment protocol. The protocol is evidence-based, meaning it was tested in clinical trials on populations and found to produce measurable outcomes on average.

This is a genuinely useful system for what it was designed to handle. When the problem is acute, specific, and fits a recognized pattern, the insurance model delivers well-defined care at scale.

The problem is that most of what chronic illness patients need is none of those things. Insurance was built to manage conditions, not to resolve the processes that cause them.

The insurance model was designed for acute, standardized, codable care. It functions exactly as designed. The issue is that chronic, system-level conditions require something the design was never built to deliver.

Where the Mismatch Happens

Here is what the insurance model requires before it will pay for care: a diagnosis.

A diagnosis means a condition that has crossed a specific threshold. Lab values outside reference ranges. Imaging showing detectable structural changes. Symptoms meeting published diagnostic criteria. Without a diagnosis that fits a billing code, there is no reimbursable care.

Here is the problem for most people with complex chronic illness: the dysfunction that's making them feel terrible exists well before those thresholds are crossed.

A cellular energy system running in significant deficit doesn't appear on standard bloodwork until it has been running that way long enough to push downstream chemistry outside reference ranges. Autonomic nervous system dysfunction doesn't have a billing code that corresponds to the specific pattern of dysregulation driving someone's fatigue and brain fog. Mitochondrial dysfunction that has been accumulating for years won't show up on the tests designed to detect whether an organ has catastrophically failed.

The gap between feeling genuinely unwell and being diagnosable is where most chronic illness patients live. And that gap is precisely the space the insurance model has no mechanism to address.

Insurance requires a diagnosis before treatment. Chronic illness often exists, sometimes for years, before it's diagnosable. The system has no pathway for that gap.

There's a second, more fundamental mismatch. The insurance model pays for procedures attached to diagnoses. It is not structured to prioritize outcomes. A rheumatologist who prescribes methotrexate for rheumatoid arthritis gets reimbursed for the prescription and the appointment, regardless of whether the patient's condition improves, stabilizes, or continues to worsen. The payment is for the procedure. Not the result.

Pattern-based evaluation, the kind that identifies why a condition developed rather than just naming the condition, doesn't have a billing code. Assessing the functional state of the autonomic nervous system across three phases of stress and recovery doesn't fit a standard insurance reimbursement structure. Identifying the specific sequence of system failures that produced a condition and designing an intervention sequence to reverse them isn't a procedure with a CPT code.

Insurance is working exactly as designed. The design just doesn't cover this.

The Problem Isn't Coverage. It's the Model.

When insurance denies coverage for a treatment approach, the implicit message is that the approach isn't valid. That if it were legitimate, it would be covered. This is one of the most damaging assumptions in chronic illness care, and it's worth examining directly.

The science underlying pattern-based, energy-system-focused care is not new or fringe. Mitochondrial medicine has been a recognized field for decades. Heart rate variability as a measure of autonomic nervous system function has been validated in clinical literature for nearly fifty years. The relationship between cellular energy production and chronic disease is documented in peer-reviewed research.

These approaches aren't uncovered because they lack scientific support. They're uncovered because they don't fit the structural requirements of the reimbursement model: standardized protocols applicable to a diagnosed condition, billable at a fixed rate, repeatable across a patient population.

An individualized assessment that produces a different map for every patient, based on their specific pattern of dysfunction, cannot be standardized into a single reimbursable protocol. That's not a scientific failure. It's a billing architecture problem.

Being uncovered by insurance does not mean an approach lacks scientific validity. It means the approach doesn't fit the structural requirements of standardized billing. Those are different problems with different implications.

The United States spends more on healthcare per capita than any nation on earth by a significant margin. It also has among the worst chronic disease outcomes in the developed world. In 1968, approximately six percent of Americans had a chronic disease. Today that number is over seventy percent. Those two data points, the most spending and the worst outcomes, tell you something about the model. Not about the people working within it.

You're not being denied care. You're being offered the wrong category of care for what you have.

Why Your Condition Was Never What Insurance Was Built For

The standard insurance treatment path for most chronic conditions follows the same structure regardless of the specific diagnosis. Identify the condition. Apply the protocol matched to that diagnosis. Manage symptoms. Adjust medication as needed. Repeat appointments.

This model works reasonably well for conditions where the mechanism is well-understood and the available treatments address the mechanism. It works for most acute conditions. It works for many infectious diseases. It works for some forms of cancer.

It does not work for conditions where the mechanism is a systemic energy failure that predates the diagnosis by years, where the available treatments address the downstream outputs of that failure rather than the failure itself, and where the individual pattern of how the system broke down determines what intervention sequence would actually reverse it.

Rheumatoid arthritis managed with methotrexate. Hashimoto's managed with levothyroxine. POTS managed with beta blockers and compression garments. Lupus managed with hydroxychloroquine. In each case, the medication addresses an output of the underlying condition. The joint inflammation. The thyroid hormone deficit. The heart rate dysregulation. The immune activation.

In each case, the underlying mechanism, the cellular energy depletion and mitochondrial dysfunction driving the immune dysregulation and tissue damage, continues untouched. The condition is managed. It isn't reversed. And the insurance model reimburses both the management and the follow-up appointments for years, because that's what the model was built to do.

There is no criticism of the practitioners involved in that care. They're working within a structure that determines what they can offer and what they can get paid for. The structure handles what it was built to handle. Chronic, system-level dysfunction isn't it.

The Risk You're Already Taking

Most people stay within the insurance-based system not because it is producing results, but because it feels safer. The familiar has a kind of gravity. You know the doctors. You know the process. You know what to expect at each appointment. There's comfort in that, even when the appointments aren't producing meaningful change.

It's worth looking at that sense of safety directly, because it deserves more scrutiny than it usually gets.

Staying in a system that isn't reversing your condition means the underlying process driving the condition continues. Not dramatically. Not all at once. But steadily. The trajectory that produced the diagnosis doesn't pause while you decide how to respond to it.

Doing nothing different is not neutral. It's a choice to continue in the same direction.

The risk of staying where you are is real. It's just familiar, which makes it feel different from the risk of doing something new. But familiarity and safety aren't the same thing. A path that isn't working is still a path. It leads somewhere.

Think about what the last year on the current path has produced. Then the year before that. The question isn't whether the current approach carries risk. Every approach does. The question is which risk you're choosing to take, and whether you're choosing it consciously or by default.

The risk you're taking now just feels familiar. That's the only thing making it feel safer.

This isn't a reason to act out of fear or urgency. It's a reason to look clearly at what staying actually means, separate from how it feels. Staying in a system you understand and a process you're comfortable with is a reasonable choice if that system is producing results. If it isn't, the comfort is real but the safety isn't.

Every path has a cost. The one that feels familiar has been charging that cost for a while. The only question worth asking honestly is whether you're getting enough back for it.

What a Different Model Actually Looks Like

The approach described in this series of articles doesn't start with a diagnosis. It starts with the question the insurance model doesn't ask: why did this person's system arrive at this state, and what specific pattern of dysfunction needs to be addressed to reverse it?

That question requires different testing. Not more bloodwork looking for disease markers, but functional assessment of the energy system: the autonomic nervous system's real-time state across rest, stress, and recovery; the cellular energy available to run the body's regulatory processes; the specific markers that reveal where breakdown is concentrated and in what sequence it occurred.

It requires individualized sequencing. The pattern that produced one person's Hashimoto's is not identical to the pattern that produced another's, even though the diagnosis is the same. The intervention sequence that addresses the first won't necessarily be the right starting point for the second. Standardized protocols applied to named diagnoses can't account for this. Individual pattern mapping can.

And it requires accepting that this kind of work doesn't fit inside insurance billing architecture. Not because it's experimental, but because it's individualized. Because it aims at the mechanism rather than the output. Because it measures and addresses things that don't have billing codes.

This is why the patients who benefit most from this approach are the ones who have already been through the conventional system thoroughly. Who already have the diagnosis, the medication, the specialist relationship, and the years of managed care that produced marginal improvement and no trajectory change. They've already answered the what. They're ready to ask the why and the how.

If you want to understand the full framework of what pattern-based evaluation involves and why it produces different outcomes than symptom management, the article

Why We Don't Treat Conditions, We Treat Patterns covers the what, why, and how distinction in depth. And if the question of why energy is the real starting point for all of it resonates, Why Energy, Not Symptoms, Is the Real Starting Point addresses the mechanism directly.

A Choice, Clearly Stated

The insurance model will continue to offer what it was built to offer: diagnosis-based, protocol-matched, symptom-managing care. For some conditions and some people, that is exactly what's needed. For many people with complex chronic illness, it is a category of care that doesn't reach the problem they actually have.

You can continue within that model. There are real reasons to do so: familiarity, cost structure, relationships with practitioners you trust. Those are legitimate considerations.

You can also explore an approach designed to address what that model doesn't measure. One that starts from the energy system rather than the symptom list. That identifies pattern rather than just condition. That aims at why rather than settling for what.

That choice is yours. Nobody else can make it for you. Not your insurance company. Not your current practitioners. Not this article.

What this article can do is make sure the choice is a real one. That you understand what each path is actually offering, and what each path is actually doing while you stay on it.

Find Out What the Pattern Behind Your Condition Actually Shows

We assess what the insurance model doesn't measure.

No diagnosis required. Your pattern is the starting point.

[ BOOK YOUR CONSULTATION ]

Dr. Rob DeMartino D.C. | Energetic Debt Method

This article is educational and does not constitute individual medical advice. Outcomes vary by patient and condition.

Frequently Asked Questions

These questions reflect what patients commonly search when they're trying to understand why the care they need isn't covered and what their options actually are.

Why doesn't insurance cover treatments for chronic illness?

Insurance was designed around acute, standardized, diagnosis-based care. It reimburses procedures attached to recognized diagnoses using fixed billing codes. Chronic illness often involves system-level dysfunction that predates a formal diagnosis, requires individualized assessment rather than standardized protocols, and aims at restoring function rather than managing symptoms. These characteristics don't fit the structural requirements of the reimbursement model. The treatments aren't uncovered because they lack validity. They're uncovered because they don't fit the billing architecture.

Does the fact that something isn't covered by insurance mean it isn't legitimate?

No. Coverage is determined by whether an intervention fits the billing architecture of the insurance model, not by whether it has scientific support. Heart rate variability testing for autonomic nervous system assessment has nearly fifty years of clinical literature behind it and is not routinely covered. Mitochondrial medicine is a recognized research field with extensive peer-reviewed documentation and is not covered by standard insurance. The reimbursement model rewards standardizable, repeatable procedures applied to diagnosed conditions. Individualized, pattern-based functional assessment doesn't fit that structure regardless of its scientific basis.

If insurance covers my specialist appointments and medications, isn't that enough?

Insurance-covered care for chronic conditions is typically designed to manage symptoms and slow progression. The medications covered are designed to modify the outputs of the underlying condition: suppressing immune responses, replacing depleted hormones, blocking specific pathways. In most cases, the underlying mechanism driving the condition, typically involving cellular energy depletion and mitochondrial dysfunction, continues unaddressed. Whether that management is enough depends on whether the trajectory of the condition is changing, holding steady, or continuing to progress despite the management.

Why would I pay out of pocket for something insurance doesn't cover?

The relevant comparison is not between covered and uncovered care. It's between what each approach actually produces. Insurance-covered care for chronic conditions provides symptom management within a framework that was not designed to reverse the underlying mechanism. Pattern-based evaluation aims at identifying and addressing that mechanism. The question worth asking is what the covered care has produced over the time you've been receiving it, and whether that trajectory is what you're prepared to continue.

Why don't more doctors offer this kind of pattern-based care if it works?

The insurance reimbursement model creates strong structural incentives toward diagnosis-based, protocol-matched care. A practice built on individualized functional assessment, pattern identification, and energy system restoration doesn't fit easily into insurance billing. It requires significantly more time per patient, more complex testing, and a results-oriented approach that isn't reimbursed at a rate that sustains a high-volume practice. The practitioners who do this work have generally made a deliberate choice to operate outside the insurance infrastructure because the infrastructure doesn't support this category of care.

How do I know if pattern-based evaluation is right for my situation?

Pattern-based evaluation is most relevant for people who already have a diagnosis, have been through conventional treatment, and have not seen the trajectory of their condition change despite appropriate management. If the what is answered but the why and how remain unanswered, that's the gap this kind of evaluation addresses. It's also relevant for people who feel genuinely unwell but whose standard labs keep coming back normal, because it evaluates functional state rather than disease markers.

Is it worth pursuing care outside the insurance model while still seeing my regular doctors?

Yes, and most patients who pursue this approach continue seeing their existing practitioners. The evaluation doesn't compete with ongoing medical management. It addresses a different level of the problem. Understanding the pattern that produced a condition doesn't require discontinuing the management of that condition. The two can run in parallel, and understanding the underlying mechanism often helps patients have more informed conversations with their existing care team.

What does it mean that insurance pays for procedures rather than outcomes?

It means the reimbursement is tied to the intervention performed, not to whether the patient's condition improves. A practitioner who manages a chronic condition for years receives ongoing reimbursement for appointments and prescriptions regardless of whether the patient's trajectory changes. This isn't a criticism of individual practitioners. It's a description of what the payment structure rewards. A model oriented toward outcomes would pay more for resolution and less for ongoing management. The current model is structured the other way.

Conventional medical care vs. Superior Health Solutions natural healthcare

Related video